Law360 (May 20, 2004, 12:00 AM EDT) -- Israeli generic drug maker Teva Pharmaceutical Industries plans to continue selling its version of Abbott Laboratories' pain medication vicoprofen, despite losing an appeal in a patent dispute.
Teva said the U.S....
Teva To Continue Selling Generic Vicoprofen After Losing Vs. Abbott At Federal Circuit
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
